Undersøgelsen af Betaferon hos patienter med en enkelt demyeliniserende hændelse omfattede 487 patienter, som fik enten Betaferon eller placebo i to år.
The study of Betaferon in patients with a single demyelinating event involved 487 patients, who received either Betaferon or a placebo for two years.